These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21617853)

  • 1. Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.
    Tada Y; Yokomizo A; Shiota M; Tsunoda T; Plass C; Naito S
    Int J Oncol; 2011 Sep; 39(3):727-33. PubMed ID: 21617853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
    Tsunoda T; Koga H; Yokomizo A; Tatsugami K; Eto M; Inokuchi J; Hirata A; Masuda K; Okumura K; Naito S
    Oncogene; 2005 Feb; 24(8):1396-402. PubMed ID: 15608674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural change due to acquired cisplatin resistance in human bladder cancer cells.
    Yoon SJ; Park I; Kwak C; Lee E
    Oncol Rep; 2003; 10(5):1363-7. PubMed ID: 12883708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer.
    Xylinas E; Hassler MR; Zhuang D; Krzywinski M; Erdem Z; Robinson BD; Elemento O; Clozel T; Shariat SF
    Biomolecules; 2016 Sep; 6(3):. PubMed ID: 27598218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
    Lee S; Yoon CY; Byun SS; Lee E; Lee SE
    J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.
    Sellar GC; Watt KP; Li L; Nelkin BD; Rabiasz GJ; Porteous DJ; Smyth JF; Gabra H
    Int J Oncol; 2002 Nov; 21(5):929-33. PubMed ID: 12370737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.
    Shiota M; Tsunoda T; Song Y; Yokomizo A; Tada Y; Oda Y; Naito S
    BJU Int; 2011 Apr; 107(7):1148-53. PubMed ID: 20726978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
    Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
    Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
    Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
    Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
    Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiyama H
    Cancer Res; 2007 Feb; 67(3):1212-20. PubMed ID: 17283157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
    Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J
    J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
    Wu ZZ; Lu HP; Chao CC
    Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.
    Zhu H; Yun F; Shi X; Wang D
    Int J Mol Med; 2015 Aug; 36(2):595-601. PubMed ID: 26080829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.